

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.07601030 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.07601030 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.74036511 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.74036511 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.20293137 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.59856992 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.50851976 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.45719991 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.45719991 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.45719991 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.43797104 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.41051741 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.30476116 |
| 14 | cysteine metabolic process (GO:0006534) | 5.20565876 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.19838508 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.11843820 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.87069127 |
| 18 | urea cycle (GO:0000050) | 4.83923896 |
| 19 | urea metabolic process (GO:0019627) | 4.83923896 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 4.80077978 |
| 21 | lysine catabolic process (GO:0006554) | 4.75395303 |
| 22 | lysine metabolic process (GO:0006553) | 4.75395303 |
| 23 | bile acid metabolic process (GO:0008206) | 4.71508614 |
| 24 | protein carboxylation (GO:0018214) | 4.68772673 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.68772673 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 4.60161129 |
| 27 | negative regulation of protein localization to cell surface (GO:2000009) | 4.56161383 |
| 28 | regulation of sarcomere organization (GO:0060297) | 4.54459675 |
| 29 | homocysteine metabolic process (GO:0050667) | 4.53860717 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.52774444 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 4.52284533 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 4.50876781 |
| 33 | cellular ketone body metabolic process (GO:0046950) | 4.50031422 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 4.45997585 |
| 35 | amino-acid betaine metabolic process (GO:0006577) | 4.45932903 |
| 36 | regulation of fibrinolysis (GO:0051917) | 4.44990634 |
| 37 | tyrosine metabolic process (GO:0006570) | 4.44400126 |
| 38 | regulation of protein activation cascade (GO:2000257) | 4.41839423 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.37913638 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.27724809 |
| 41 | alpha-amino acid catabolic process (GO:1901606) | 4.27151367 |
| 42 | acylglycerol homeostasis (GO:0055090) | 4.17840143 |
| 43 | triglyceride homeostasis (GO:0070328) | 4.17840143 |
| 44 | regulation of cholesterol esterification (GO:0010872) | 4.17648994 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.13630072 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.13630072 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.13630072 |
| 48 | primary alcohol catabolic process (GO:0034310) | 4.13607088 |
| 49 | regulation of complement activation (GO:0030449) | 4.13516157 |
| 50 | coenzyme catabolic process (GO:0009109) | 4.12731905 |
| 51 | bile acid and bile salt transport (GO:0015721) | 4.11090136 |
| 52 | cellular glucuronidation (GO:0052695) | 4.10735561 |
| 53 | phospholipid efflux (GO:0033700) | 4.08950773 |
| 54 | short-chain fatty acid metabolic process (GO:0046459) | 4.08524630 |
| 55 | drug catabolic process (GO:0042737) | 4.05247916 |
| 56 | cellular amino acid catabolic process (GO:0009063) | 4.03188505 |
| 57 | glutamate metabolic process (GO:0006536) | 4.00379455 |
| 58 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.00347469 |
| 59 | ethanol oxidation (GO:0006069) | 3.97358344 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 3.96951815 |
| 61 | negative regulation of sterol transport (GO:0032372) | 3.96260845 |
| 62 | negative regulation of cholesterol transport (GO:0032375) | 3.96260845 |
| 63 | drug transmembrane transport (GO:0006855) | 3.95142666 |
| 64 | ketone body metabolic process (GO:1902224) | 3.93313956 |
| 65 | cellular modified amino acid catabolic process (GO:0042219) | 3.90262230 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 3.87076562 |
| 67 | acetyl-CoA metabolic process (GO:0006084) | 3.86532253 |
| 68 | benzene-containing compound metabolic process (GO:0042537) | 3.81780224 |
| 69 | cholesterol efflux (GO:0033344) | 3.80478723 |
| 70 | cellular biogenic amine catabolic process (GO:0042402) | 3.78903294 |
| 71 | amine catabolic process (GO:0009310) | 3.78903294 |
| 72 | regulation of cholesterol homeostasis (GO:2000188) | 3.76245156 |
| 73 | glucuronate metabolic process (GO:0019585) | 3.75622058 |
| 74 | uronic acid metabolic process (GO:0006063) | 3.75622058 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 3.72797454 |
| 76 | * fatty acid beta-oxidation (GO:0006635) | 3.70457149 |
| 77 | ethanol metabolic process (GO:0006067) | 3.69706243 |
| 78 | * organic acid catabolic process (GO:0016054) | 3.67153787 |
| 79 | * carboxylic acid catabolic process (GO:0046395) | 3.67153787 |
| 80 | * fatty acid oxidation (GO:0019395) | 3.66658526 |
| 81 | epoxygenase P450 pathway (GO:0019373) | 3.65924487 |
| 82 | ribonucleoprotein complex disassembly (GO:0032988) | 3.65191808 |
| 83 | plasma membrane repair (GO:0001778) | 3.62373230 |
| 84 | imidazole-containing compound metabolic process (GO:0052803) | 3.62077321 |
| 85 | aspartate family amino acid catabolic process (GO:0009068) | 3.61113382 |
| 86 | * monocarboxylic acid catabolic process (GO:0072329) | 3.60948299 |
| 87 | * lipid oxidation (GO:0034440) | 3.59800643 |
| 88 | phospholipid homeostasis (GO:0055091) | 3.58162458 |
| 89 | regulation of bile acid biosynthetic process (GO:0070857) | 3.56843620 |
| 90 | glycine metabolic process (GO:0006544) | 3.56520991 |
| 91 | * fatty acid catabolic process (GO:0009062) | 3.56130930 |
| 92 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.52948571 |
| 93 | plasma lipoprotein particle assembly (GO:0034377) | 3.52480599 |
| 94 | aldehyde catabolic process (GO:0046185) | 3.50710846 |
| 95 | negative regulation of lipase activity (GO:0060192) | 3.49446633 |
| 96 | positive regulation of lipid catabolic process (GO:0050996) | 3.48820859 |
| 97 | flavonoid metabolic process (GO:0009812) | 3.47488636 |
| 98 | carnitine metabolic process (GO:0009437) | 3.47177579 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.46173711 |
| 100 | intestinal cholesterol absorption (GO:0030299) | 3.43034491 |
| 101 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.42790202 |
| 102 | exogenous drug catabolic process (GO:0042738) | 3.42556800 |
| 103 | regulation of cholesterol metabolic process (GO:0090181) | 3.42529627 |
| 104 | sterol homeostasis (GO:0055092) | 3.42368583 |
| 105 | urate metabolic process (GO:0046415) | 3.42181245 |
| 106 | low-density lipoprotein particle remodeling (GO:0034374) | 3.42120236 |
| 107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.41735625 |
| 108 | response to nitrosative stress (GO:0051409) | 3.40913179 |
| 109 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.33175689 |
| 110 | COPII vesicle coating (GO:0048208) | 3.14707564 |
| 111 | desmosome organization (GO:0002934) | 3.10570754 |
| 112 | negative regulation of protein activation cascade (GO:2000258) | 3.05955396 |
| 113 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.98940091 |
| 114 | polyketide metabolic process (GO:0030638) | 2.97294000 |
| 115 | doxorubicin metabolic process (GO:0044598) | 2.97294000 |
| 116 | daunorubicin metabolic process (GO:0044597) | 2.97294000 |
| 117 | midgut development (GO:0007494) | 2.96522552 |
| 118 | organelle disassembly (GO:1903008) | 2.92206678 |
| 119 | omega-hydroxylase P450 pathway (GO:0097267) | 2.89091458 |
| 120 | regulation of skeletal muscle contraction (GO:0014819) | 2.87605564 |
| 121 | negative regulation of heart growth (GO:0061117) | 2.86047022 |
| 122 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.86047022 |
| 123 | intestinal absorption (GO:0050892) | 2.85378529 |
| 124 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.81210521 |
| 125 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.73058119 |
| 126 | embryonic foregut morphogenesis (GO:0048617) | 2.73034956 |
| 127 | negative regulation of complement activation (GO:0045916) | 2.71397897 |
| 128 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.66003143 |
| 129 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.63348448 |
| 130 | membrane assembly (GO:0071709) | 2.61956386 |
| 131 | negative regulation of muscle hypertrophy (GO:0014741) | 2.55853341 |
| 132 | polyol biosynthetic process (GO:0046173) | 2.54133115 |
| 133 | drug metabolic process (GO:0017144) | 2.52436361 |
| 134 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.52191920 |
| 135 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.48666644 |
| 136 | muscle cell cellular homeostasis (GO:0046716) | 2.47403805 |
| 137 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.46280629 |
| 138 | primary alcohol metabolic process (GO:0034308) | 2.46118457 |
| 139 | oxidative demethylation (GO:0070989) | 2.45144831 |
| 140 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.44567421 |
| 141 | Golgi transport vesicle coating (GO:0048200) | 2.42363652 |
| 142 | COPI coating of Golgi vesicle (GO:0048205) | 2.42363652 |
| 143 | cholesterol biosynthetic process (GO:0006695) | 2.42027920 |
| 144 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.41985493 |
| 145 | mitotic sister chromatid cohesion (GO:0007064) | 2.41967170 |
| 146 | peroxisome fission (GO:0016559) | 2.38271369 |
| 147 | regulation of protein localization to cell surface (GO:2000008) | 2.34421807 |
| 148 | regulation of sister chromatid cohesion (GO:0007063) | 2.34326633 |
| 149 | postreplication repair (GO:0006301) | 2.27798715 |
| 150 | nuclear pore complex assembly (GO:0051292) | 2.26359538 |
| 151 | negative regulation of organelle assembly (GO:1902116) | 2.22494905 |
| 152 | heme transport (GO:0015886) | 2.19238456 |
| 153 | eye photoreceptor cell differentiation (GO:0001754) | 2.18581659 |
| 154 | photoreceptor cell differentiation (GO:0046530) | 2.18581659 |
| 155 | membrane budding (GO:0006900) | 2.18361303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.41460581 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.36943417 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.94731116 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.80065186 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.75520746 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.72046182 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.17074625 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.79671386 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.20725532 |
| 10 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.95584097 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.50110967 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.49415653 |
| 13 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.42268609 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.36804131 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.32962499 |
| 16 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.18258128 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.13628913 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09565092 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 2.01877290 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.3208370 |
| 21 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.89873633 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88327054 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.83369379 |
| 24 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.75735208 |
| 25 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.75125151 |
| 26 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.71163171 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.69460861 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.68603098 |
| 29 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.63504360 |
| 30 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.62823246 |
| 31 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.58615745 |
| 32 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.53124652 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.51209372 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49607685 |
| 35 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.49031113 |
| 36 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40992099 |
| 37 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.40051729 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39513114 |
| 39 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.38430552 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36932555 |
| 41 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.35286213 |
| 42 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.34316936 |
| 43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33376745 |
| 44 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30746478 |
| 45 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.30713437 |
| 46 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.27998102 |
| 47 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.27444717 |
| 48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26828800 |
| 49 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24700668 |
| 50 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.24507259 |
| 51 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.24064625 |
| 52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.24003927 |
| 53 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.23854152 |
| 54 | EWS_26573619_Chip-Seq_HEK293_Human | 1.23819412 |
| 55 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.21277545 |
| 56 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20178882 |
| 57 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.19421021 |
| 58 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.18332274 |
| 59 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.17695567 |
| 60 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.16472143 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16213838 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15940338 |
| 63 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14796632 |
| 64 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14664363 |
| 65 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14042896 |
| 66 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12270815 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11837030 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11727888 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11665466 |
| 70 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11580740 |
| 71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11272713 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11272713 |
| 73 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10656963 |
| 74 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10369360 |
| 75 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.08874840 |
| 76 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08352761 |
| 77 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07978823 |
| 78 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.07370267 |
| 79 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.05668906 |
| 80 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.05543904 |
| 81 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05004476 |
| 82 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.04491684 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04435866 |
| 84 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04137066 |
| 85 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.03815973 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03734554 |
| 87 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.03131740 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02929369 |
| 89 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02661769 |
| 90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01646435 |
| 91 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01261744 |
| 92 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.00694123 |
| 93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00693949 |
| 94 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00006579 |
| 95 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00006579 |
| 96 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.99896351 |
| 97 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.99600597 |
| 98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99480992 |
| 99 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98860528 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98418343 |
| 101 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92920091 |
| 102 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91049534 |
| 103 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89314391 |
| 104 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88062684 |
| 105 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86652148 |
| 106 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.85459214 |
| 107 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.85206162 |
| 108 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.83589264 |
| 109 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.81541129 |
| 110 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80482950 |
| 111 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79821978 |
| 112 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79669165 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78946189 |
| 114 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76012927 |
| 115 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.75706460 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.75577984 |
| 117 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74910826 |
| 118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.73711487 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72085999 |
| 120 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70854610 |
| 121 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.69906496 |
| 122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69020363 |
| 123 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.68036894 |
| 124 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.67325418 |
| 125 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.66273209 |
| 126 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.65038751 |
| 127 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.64105367 |
| 128 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.61798966 |
| 129 | CBP_21632823_ChIP-Seq_H3396_Human | 0.61156197 |
| 130 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.60619144 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.60591665 |
| 132 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.59999630 |
| 133 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.59977378 |
| 134 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58507842 |
| 135 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58284392 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57649145 |
| 137 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.56796222 |
| 138 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.55664964 |
| 139 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.54817342 |
| 140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.54390068 |
| 141 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.54147498 |
| 142 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.53985129 |
| 143 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.53820766 |
| 144 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.53578585 |
| 145 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53322161 |
| 146 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.53194040 |
| 147 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.53194040 |
| 148 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.53028785 |
| 149 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53019891 |
| 150 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.52987587 |
| 151 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.51912020 |
| 152 | GATA1_19941826_ChIP-Seq_K562_Human | 0.51780768 |
| 153 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.51510217 |
| 154 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.50847649 |
| 155 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.49747996 |
| 156 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.48925647 |
| 157 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.48836576 |
| 158 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.48827515 |
| 159 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.48649446 |
| 160 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48559942 |
| 161 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.48092701 |
| 162 | GATA2_19941826_ChIP-Seq_K562_Human | 0.47113761 |
| 163 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.46885287 |
| 164 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.46546903 |
| 165 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46420671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.95131850 |
| 2 | MP0005360_urolithiasis | 7.09761965 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.10135215 |
| 4 | MP0005365_abnormal_bile_salt | 5.94060753 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.91511798 |
| 6 | MP0003950_abnormal_plasma_membrane | 4.00903167 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.90047110 |
| 8 | MP0003252_abnormal_bile_duct | 3.88541708 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.35735226 |
| 10 | MP0003195_calcinosis | 3.25657596 |
| 11 | MP0005083_abnormal_biliary_tract | 2.99306139 |
| 12 | MP0005332_abnormal_amino_acid | 2.88899655 |
| 13 | MP0009840_abnormal_foam_cell | 2.88839305 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.82489076 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.27744581 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.22700647 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.20455821 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.16855933 |
| 19 | MP0000609_abnormal_liver_physiology | 1.99713807 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.94009523 |
| 21 | MP0004272_abnormal_basement_membrane | 1.88560549 |
| 22 | MP0005187_abnormal_penis_morphology | 1.87224099 |
| 23 | MP0003868_abnormal_feces_composition | 1.85048396 |
| 24 | MP0000751_myopathy | 1.76427096 |
| 25 | MP0004270_analgesia | 1.70123315 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.68273482 |
| 27 | MP0002102_abnormal_ear_morphology | 1.55768710 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.55379720 |
| 29 | MP0002009_preneoplasia | 1.53706873 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53324307 |
| 31 | MP0000749_muscle_degeneration | 1.51490819 |
| 32 | MP0005623_abnormal_meninges_morphology | 1.49808566 |
| 33 | MP0004084_abnormal_cardiac_muscle | 1.48543490 |
| 34 | MP0005451_abnormal_body_composition | 1.44912430 |
| 35 | MP0001764_abnormal_homeostasis | 1.44288578 |
| 36 | MP0004043_abnormal_pH_regulation | 1.32532621 |
| 37 | MP0010678_abnormal_skin_adnexa | 1.30388457 |
| 38 | MP0003941_abnormal_skin_development | 1.29717101 |
| 39 | MP0008057_abnormal_DNA_replication | 1.21250663 |
| 40 | MP0009697_abnormal_copulation | 1.18628288 |
| 41 | MP0003186_abnormal_redox_activity | 1.18018785 |
| 42 | MP0003718_maternal_effect | 1.17597957 |
| 43 | MP0000647_abnormal_sebaceous_gland | 1.14326131 |
| 44 | MP0010094_abnormal_chromosome_stability | 1.13120334 |
| 45 | MP0004215_abnormal_myocardial_fiber | 1.12658239 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 1.12258806 |
| 47 | MP0003011_delayed_dark_adaptation | 1.09766610 |
| 48 | MP0005330_cardiomyopathy | 1.09468421 |
| 49 | MP0000537_abnormal_urethra_morphology | 1.05420307 |
| 50 | MP0002234_abnormal_pharynx_morphology | 1.04863598 |
| 51 | MP0002233_abnormal_nose_morphology | 1.03852193 |
| 52 | MP0002078_abnormal_glucose_homeostasis | 1.03003358 |
| 53 | MP0000604_amyloidosis | 1.01527509 |
| 54 | MP0005220_abnormal_exocrine_pancreas | 1.00203725 |
| 55 | MP0005647_abnormal_sex_gland | 0.99430296 |
| 56 | MP0005408_hypopigmentation | 0.98457162 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 0.98384151 |
| 58 | MP0000598_abnormal_liver_morphology | 0.97968926 |
| 59 | MP0002254_reproductive_system_inflammat | 0.97573584 |
| 60 | MP0001299_abnormal_eye_distance/ | 0.95594215 |
| 61 | MP0005670_abnormal_white_adipose | 0.95170312 |
| 62 | MP0002697_abnormal_eye_size | 0.94787752 |
| 63 | MP0004130_abnormal_muscle_cell | 0.94637216 |
| 64 | MP0001293_anophthalmia | 0.94132140 |
| 65 | MP0002269_muscular_atrophy | 0.93620254 |
| 66 | MP0003385_abnormal_body_wall | 0.93455872 |
| 67 | MP0002876_abnormal_thyroid_physiology | 0.92997101 |
| 68 | MP0001756_abnormal_urination | 0.91870335 |
| 69 | MP0000467_abnormal_esophagus_morphology | 0.90671798 |
| 70 | MP0002896_abnormal_bone_mineralization | 0.88428874 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 0.88352719 |
| 72 | MP0006138_congestive_heart_failure | 0.87976488 |
| 73 | MP0003329_amyloid_beta_deposits | 0.86915565 |
| 74 | MP0005535_abnormal_body_temperature | 0.86373770 |
| 75 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86338276 |
| 76 | MP0002971_abnormal_brown_adipose | 0.86080767 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.85846368 |
| 78 | MP0002092_abnormal_eye_morphology | 0.85064271 |
| 79 | MP0009642_abnormal_blood_homeostasis | 0.84736254 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 0.83782268 |
| 81 | MP0002837_dystrophic_cardiac_calcinosis | 0.82538832 |
| 82 | MP0009780_abnormal_chondrocyte_physiolo | 0.80495239 |
| 83 | MP0003937_abnormal_limbs/digits/tail_de | 0.80320494 |
| 84 | MP0000462_abnormal_digestive_system | 0.80207523 |
| 85 | MP0000383_abnormal_hair_follicle | 0.79831770 |
| 86 | MP0003690_abnormal_glial_cell | 0.79609256 |
| 87 | MP0001915_intracranial_hemorrhage | 0.78912575 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 0.78642188 |
| 89 | MP0005409_darkened_coat_color | 0.78632798 |
| 90 | MP0009764_decreased_sensitivity_to | 0.77592770 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.76032328 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.75824195 |
| 93 | MP0001661_extended_life_span | 0.75512129 |
| 94 | MP0002796_impaired_skin_barrier | 0.75020228 |
| 95 | MP0009763_increased_sensitivity_to | 0.74707606 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.73502999 |
| 97 | MP0005334_abnormal_fat_pad | 0.73302929 |
| 98 | MP0004036_abnormal_muscle_relaxation | 0.71053044 |
| 99 | MP0000762_abnormal_tongue_morphology | 0.71045475 |
| 100 | MP0002282_abnormal_trachea_morphology | 0.69925111 |
| 101 | MP0003566_abnormal_cell_adhesion | 0.69921785 |
| 102 | MP0008058_abnormal_DNA_repair | 0.69330197 |
| 103 | MP0004957_abnormal_blastocyst_morpholog | 0.68844571 |
| 104 | MP0000377_abnormal_hair_follicle | 0.68830565 |
| 105 | MP0005376_homeostasis/metabolism_phenot | 0.67852973 |
| 106 | MP0008932_abnormal_embryonic_tissue | 0.67807620 |
| 107 | MP0002938_white_spotting | 0.67329129 |
| 108 | MP0010030_abnormal_orbit_morphology | 0.67002750 |
| 109 | MP0002972_abnormal_cardiac_muscle | 0.66650813 |
| 110 | MP0004484_altered_response_of | 0.66287022 |
| 111 | MP0003111_abnormal_nucleus_morphology | 0.65812488 |
| 112 | MP0005448_abnormal_energy_balance | 0.65067344 |
| 113 | MP0009384_cardiac_valve_regurgitation | 0.64659724 |
| 114 | MP0005666_abnormal_adipose_tissue | 0.64534073 |
| 115 | MP0002638_abnormal_pupillary_reflex | 0.63748674 |
| 116 | MP0008469_abnormal_protein_level | 0.63361676 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.62943120 |
| 118 | MP0008775_abnormal_heart_ventricle | 0.62495423 |
| 119 | MP0003935_abnormal_craniofacial_develop | 0.62279460 |
| 120 | MP0010307_abnormal_tumor_latency | 0.61774536 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.60399592 |
| 122 | MP0003567_abnormal_fetal_cardiomyocyte | 0.59822168 |
| 123 | MP0002084_abnormal_developmental_patter | 0.59772695 |
| 124 | MP0005391_vision/eye_phenotype | 0.58401907 |
| 125 | MP0005058_abnormal_lysosome_morphology | 0.57873141 |
| 126 | MP0001270_distended_abdomen | 0.57844782 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.57824223 |
| 128 | MP0005266_abnormal_metabolism | 0.57808379 |
| 129 | MP0000639_abnormal_adrenal_gland | 0.57541873 |
| 130 | MP0003953_abnormal_hormone_level | 0.57305465 |
| 131 | MP0005367_renal/urinary_system_phenotyp | 0.57079014 |
| 132 | MP0000516_abnormal_urinary_system | 0.57079014 |
| 133 | MP0004264_abnormal_extraembryonic_tissu | 0.56962266 |
| 134 | MP0003693_abnormal_embryo_hatching | 0.56283920 |
| 135 | MP0001944_abnormal_pancreas_morphology | 0.56220213 |
| 136 | MP0005501_abnormal_skin_physiology | 0.55977106 |
| 137 | MP0005248_abnormal_Harderian_gland | 0.55354974 |
| 138 | MP0000230_abnormal_systemic_arterial | 0.55020421 |
| 139 | MP0000579_abnormal_nail_morphology | 0.54892398 |
| 140 | MP0002928_abnormal_bile_duct | 0.52293213 |
| 141 | MP0006035_abnormal_mitochondrial_morpho | 0.49605264 |
| 142 | MP0002168_other_aberrant_phenotype | 0.47219995 |
| 143 | MP0003300_gastrointestinal_ulcer | 0.47145158 |
| 144 | MP0009053_abnormal_anal_canal | 0.46587635 |
| 145 | MP0005395_other_phenotype | 0.43422765 |
| 146 | MP0002822_catalepsy | 0.42356420 |
| 147 | MP0003638_abnormal_response/metabolism_ | 0.41730174 |
| 148 | MP0000538_abnormal_urinary_bladder | 0.38717141 |
| 149 | MP0002090_abnormal_vision | 0.37552878 |
| 150 | MP0002295_abnormal_pulmonary_circulatio | 0.37213268 |
| 151 | MP0003959_abnormal_lean_body | 0.36329948 |
| 152 | MP0000566_synostosis | 0.34793928 |
| 153 | MP0002060_abnormal_skin_morphology | 0.34550783 |
| 154 | MP0005375_adipose_tissue_phenotype | 0.34475304 |
| 155 | MP0002693_abnormal_pancreas_physiology | 0.34242237 |
| 156 | MP0004185_abnormal_adipocyte_glucose | 0.33375889 |
| 157 | MP0001881_abnormal_mammary_gland | 0.33332755 |
| 158 | MP0004381_abnormal_hair_follicle | 0.32632393 |
| 159 | MP0002098_abnormal_vibrissa_morphology | 0.32395170 |
| 160 | MP0009672_abnormal_birth_weight | 0.31504196 |
| 161 | MP0002909_abnormal_adrenal_gland | 0.30997854 |
| 162 | MP0001177_atelectasis | 0.30769493 |
| 163 | MP0000427_abnormal_hair_cycle | 0.29210031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.94526642 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.87914030 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.30347601 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.96586700 |
| 5 | Xanthomatosis (HP:0000991) | 5.90540418 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.66941056 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.57033101 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 4.97862338 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.94003728 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.73658557 |
| 11 | Ketosis (HP:0001946) | 4.58905087 |
| 12 | Complement deficiency (HP:0004431) | 4.52544849 |
| 13 | Calf muscle hypertrophy (HP:0008981) | 4.52309884 |
| 14 | Hyperammonemia (HP:0001987) | 4.46899316 |
| 15 | Epidermoid cyst (HP:0200040) | 4.35261286 |
| 16 | Hyperglycinemia (HP:0002154) | 4.33949895 |
| 17 | Hyperglycinuria (HP:0003108) | 4.32968441 |
| 18 | Hypolipoproteinemia (HP:0010981) | 4.31724735 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.17769783 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 4.17769783 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.14910975 |
| 22 | Fat malabsorption (HP:0002630) | 4.04445343 |
| 23 | Subaortic stenosis (HP:0001682) | 4.00902357 |
| 24 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.00902357 |
| 25 | Exercise-induced myalgia (HP:0003738) | 3.99468648 |
| 26 | Conjugated hyperbilirubinemia (HP:0002908) | 3.99126857 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.97376709 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.93723609 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.92910008 |
| 30 | Ketoacidosis (HP:0001993) | 3.90736067 |
| 31 | Joint hemorrhage (HP:0005261) | 3.88911207 |
| 32 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.86165939 |
| 33 | Increased serum pyruvate (HP:0003542) | 3.86091230 |
| 34 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.85912734 |
| 35 | Hypoalphalipoproteinemia (HP:0003233) | 3.79521165 |
| 36 | Abnormality of methionine metabolism (HP:0010901) | 3.72095850 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.63461277 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 3.54695183 |
| 39 | Abnormality of glycolysis (HP:0004366) | 3.53675587 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.42591127 |
| 41 | Hypoglycemic seizures (HP:0002173) | 3.28937227 |
| 42 | Gout (HP:0001997) | 3.28293513 |
| 43 | Hypercholesterolemia (HP:0003124) | 3.26117363 |
| 44 | Abnormality of complement system (HP:0005339) | 3.19157528 |
| 45 | Hyperbilirubinemia (HP:0002904) | 3.16994911 |
| 46 | Abnormality of purine metabolism (HP:0004352) | 3.13096737 |
| 47 | Delayed CNS myelination (HP:0002188) | 3.08605085 |
| 48 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02036021 |
| 49 | Arterial tortuosity (HP:0005116) | 2.95823382 |
| 50 | Metabolic acidosis (HP:0001942) | 2.92046949 |
| 51 | Steatorrhea (HP:0002570) | 2.91932673 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.90323200 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.90323200 |
| 54 | Skin nodule (HP:0200036) | 2.88410827 |
| 55 | Generalized aminoaciduria (HP:0002909) | 2.88293823 |
| 56 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.87305655 |
| 57 | Abnormality of serum amino acid levels (HP:0003112) | 2.85563894 |
| 58 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.79914590 |
| 59 | Hepatocellular carcinoma (HP:0001402) | 2.70387412 |
| 60 | Vascular tortuosity (HP:0004948) | 2.69767628 |
| 61 | Lethargy (HP:0001254) | 2.64780710 |
| 62 | Abnormality of the calf musculature (HP:0001430) | 2.59735473 |
| 63 | Asymmetric septal hypertrophy (HP:0001670) | 2.59687815 |
| 64 | Sudden death (HP:0001699) | 2.59382574 |
| 65 | Vascular calcification (HP:0004934) | 2.54703177 |
| 66 | Symptomatic seizures (HP:0011145) | 2.51949936 |
| 67 | Myocardial infarction (HP:0001658) | 2.44643945 |
| 68 | Papillary thyroid carcinoma (HP:0002895) | 2.43835293 |
| 69 | Irritability (HP:0000737) | 2.42325048 |
| 70 | Late onset (HP:0003584) | 2.41918718 |
| 71 | Cerebral edema (HP:0002181) | 2.40455669 |
| 72 | Acanthocytosis (HP:0001927) | 2.39395239 |
| 73 | Malnutrition (HP:0004395) | 2.36448449 |
| 74 | Proximal tubulopathy (HP:0000114) | 2.35391963 |
| 75 | Sensorimotor neuropathy (HP:0007141) | 2.34252928 |
| 76 | Abnormal gallbladder morphology (HP:0012437) | 2.34144100 |
| 77 | Hyperglycemia (HP:0003074) | 2.33185470 |
| 78 | Enlarged kidneys (HP:0000105) | 2.31056065 |
| 79 | Popliteal pterygium (HP:0009756) | 2.30928304 |
| 80 | Alkalosis (HP:0001948) | 2.30712069 |
| 81 | Abnormality of urine glucose concentration (HP:0011016) | 2.28455238 |
| 82 | Glycosuria (HP:0003076) | 2.28455238 |
| 83 | Cardiovascular calcification (HP:0011915) | 2.26083712 |
| 84 | Hypochromic microcytic anemia (HP:0004840) | 2.23891772 |
| 85 | Spastic diplegia (HP:0001264) | 2.23528114 |
| 86 | Increased purine levels (HP:0004368) | 2.23290873 |
| 87 | Hyperuricemia (HP:0002149) | 2.23290873 |
| 88 | Vomiting (HP:0002013) | 2.22947993 |
| 89 | Spontaneous abortion (HP:0005268) | 2.21881303 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.21278109 |
| 91 | Pancreatitis (HP:0001733) | 2.21261756 |
| 92 | Abnormality of proline metabolism (HP:0010907) | 2.18189706 |
| 93 | Hydroxyprolinuria (HP:0003080) | 2.18189706 |
| 94 | Rickets (HP:0002748) | 2.12867538 |
| 95 | Cholelithiasis (HP:0001081) | 2.12770438 |
| 96 | Neonatal onset (HP:0003623) | 2.05591103 |
| 97 | Abnormality of the astrocytes (HP:0100707) | 2.05360040 |
| 98 | Astrocytoma (HP:0009592) | 2.05360040 |
| 99 | Mitral stenosis (HP:0001718) | 2.04932449 |
| 100 | Patchy hypopigmentation of hair (HP:0011365) | 2.00676760 |
| 101 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.98758687 |
| 102 | Abnormal gallbladder physiology (HP:0012438) | 1.98723759 |
| 103 | Cholecystitis (HP:0001082) | 1.98723759 |
| 104 | Esophageal varix (HP:0002040) | 1.98704867 |
| 105 | Glomerulonephritis (HP:0000099) | 1.97468781 |
| 106 | Abnormality of vitamin metabolism (HP:0100508) | 1.95511192 |
| 107 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.93792856 |
| 108 | Amyloidosis (HP:0011034) | 1.93544727 |
| 109 | Abnormality of the gallbladder (HP:0005264) | 1.92915958 |
| 110 | Fair hair (HP:0002286) | 1.92627712 |
| 111 | Opisthotonus (HP:0002179) | 1.86593917 |
| 112 | Volvulus (HP:0002580) | 1.84794080 |
| 113 | Gowers sign (HP:0003391) | 1.83514066 |
| 114 | Thyroid carcinoma (HP:0002890) | 1.83004684 |
| 115 | Pheochromocytoma (HP:0002666) | 1.81591298 |
| 116 | Acute hepatic failure (HP:0006554) | 1.80926839 |
| 117 | Muscle stiffness (HP:0003552) | 1.79041548 |
| 118 | Elevated alkaline phosphatase (HP:0003155) | 1.78615622 |
| 119 | Pili torti (HP:0003777) | 1.78174416 |
| 120 | Decreased lacrimation (HP:0000633) | 1.77021643 |
| 121 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75692251 |
| 122 | Hypophosphatemic rickets (HP:0004912) | 1.75496584 |
| 123 | Osteomalacia (HP:0002749) | 1.74916137 |
| 124 | Myoglobinuria (HP:0002913) | 1.72524760 |
| 125 | Abnormality of macular pigmentation (HP:0008002) | 1.72154093 |
| 126 | Hemorrhage of the eye (HP:0011885) | 1.72036554 |
| 127 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.71546546 |
| 128 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.71546546 |
| 129 | Elevated hepatic transaminases (HP:0002910) | 1.71033025 |
| 130 | Overlapping toe (HP:0001845) | 1.67048523 |
| 131 | * Abnormal biliary tract morphology (HP:0012440) | 1.66031741 |
| 132 | Right ventricular cardiomyopathy (HP:0011663) | 1.65857025 |
| 133 | Termporal pattern (HP:0011008) | 1.65291256 |
| 134 | Insidious onset (HP:0003587) | 1.65291256 |
| 135 | Abnormal auditory evoked potentials (HP:0006958) | 1.64944000 |
| 136 | Tubulointerstitial nephritis (HP:0001970) | 1.63919003 |
| 137 | Abnormal tarsal ossification (HP:0008369) | 1.63116357 |
| 138 | Bifid scrotum (HP:0000048) | 1.62107395 |
| 139 | Abnormal foot bone ossification (HP:0010675) | 1.60911313 |
| 140 | Myotonia (HP:0002486) | 1.60486848 |
| 141 | Asymmetry of the thorax (HP:0001555) | 1.58063498 |
| 142 | Megaloblastic anemia (HP:0001889) | 1.57057989 |
| 143 | Pterygium (HP:0001059) | 1.53954446 |
| 144 | Ependymoma (HP:0002888) | 1.53283620 |
| 145 | White forelock (HP:0002211) | 1.51381689 |
| 146 | Focal segmental glomerulosclerosis (HP:0000097) | 1.49772929 |
| 147 | Hyperactive renin-angiotensin system (HP:0000841) | 1.49029658 |
| 148 | Glioma (HP:0009733) | 1.48812321 |
| 149 | Rhinitis (HP:0012384) | 1.47555731 |
| 150 | Small epiphyses (HP:0010585) | 1.46684551 |
| 151 | Neck muscle weakness (HP:0000467) | 1.44489915 |
| 152 | Curly hair (HP:0002212) | 1.44282808 |
| 153 | Glomerulosclerosis (HP:0000096) | 1.43837386 |
| 154 | Alacrima (HP:0000522) | 1.42173861 |
| 155 | Barrel-shaped chest (HP:0001552) | 1.41263410 |
| 156 | Childhood onset (HP:0011463) | 1.40095323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.09040854 |
| 2 | INSRR | 4.25668742 |
| 3 | SIK1 | 3.84316445 |
| 4 | FGFR4 | 3.26446982 |
| 5 | ERN1 | 3.19468707 |
| 6 | TAOK3 | 2.77137127 |
| 7 | MAPKAPK5 | 2.54865017 |
| 8 | FRK | 2.54636712 |
| 9 | EIF2AK3 | 2.44307002 |
| 10 | MST1R | 2.43451463 |
| 11 | WEE1 | 2.38814834 |
| 12 | ERBB4 | 2.36413096 |
| 13 | SCYL2 | 2.34786854 |
| 14 | MST4 | 2.24413907 |
| 15 | BCR | 2.22985121 |
| 16 | BRSK2 | 2.12777984 |
| 17 | EIF2AK1 | 2.12434741 |
| 18 | WNK4 | 2.01654918 |
| 19 | CDK8 | 1.99779393 |
| 20 | CCNB1 | 1.99366176 |
| 21 | CASK | 1.98840815 |
| 22 | LATS1 | 1.97393675 |
| 23 | TRIB3 | 1.89563921 |
| 24 | ERBB3 | 1.86808620 |
| 25 | NEK1 | 1.83958138 |
| 26 | MAPK15 | 1.81253215 |
| 27 | FGFR2 | 1.78059094 |
| 28 | PIK3CG | 1.69271614 |
| 29 | MUSK | 1.63836892 |
| 30 | EPHB1 | 1.58834844 |
| 31 | PTK6 | 1.57126191 |
| 32 | MAP2K4 | 1.56531534 |
| 33 | ACVR1B | 1.54729762 |
| 34 | MET | 1.50740263 |
| 35 | WNK3 | 1.50344905 |
| 36 | PKN2 | 1.48668365 |
| 37 | STK3 | 1.46427176 |
| 38 | BMPR1B | 1.45869341 |
| 39 | FLT3 | 1.43864437 |
| 40 | EPHA2 | 1.42212668 |
| 41 | TRIM28 | 1.40025815 |
| 42 | MAP3K2 | 1.35468593 |
| 43 | OXSR1 | 1.32338478 |
| 44 | SRPK1 | 1.30330616 |
| 45 | DMPK | 1.27319152 |
| 46 | MAP3K12 | 1.27310289 |
| 47 | MAPK11 | 1.26915014 |
| 48 | TTK | 1.23566676 |
| 49 | PNCK | 1.23343281 |
| 50 | STK39 | 1.19432735 |
| 51 | MAP3K7 | 1.16179585 |
| 52 | PRKAA2 | 1.15516272 |
| 53 | PINK1 | 1.15084316 |
| 54 | NEK9 | 1.13801965 |
| 55 | STK38L | 1.13181646 |
| 56 | MELK | 1.09248690 |
| 57 | PLK2 | 1.06554098 |
| 58 | ERBB2 | 1.05266856 |
| 59 | PDK4 | 1.04322842 |
| 60 | PDK3 | 1.04322842 |
| 61 | ABL2 | 1.00257582 |
| 62 | PLK3 | 0.98854352 |
| 63 | PAK3 | 0.98326211 |
| 64 | MKNK2 | 0.97109752 |
| 65 | MAP3K4 | 0.96499497 |
| 66 | TNIK | 0.96234618 |
| 67 | DAPK2 | 0.94791508 |
| 68 | EPHA3 | 0.93474640 |
| 69 | SGK223 | 0.93236202 |
| 70 | SGK494 | 0.93236202 |
| 71 | TSSK6 | 0.93151221 |
| 72 | JAK2 | 0.92317917 |
| 73 | PTK2 | 0.92074855 |
| 74 | MAP3K3 | 0.88166087 |
| 75 | GSK3A | 0.87728574 |
| 76 | FER | 0.87243479 |
| 77 | CSNK1G3 | 0.86977984 |
| 78 | RIPK1 | 0.85435174 |
| 79 | LMTK2 | 0.84022810 |
| 80 | NEK6 | 0.83499550 |
| 81 | KSR1 | 0.83129599 |
| 82 | BRSK1 | 0.81227838 |
| 83 | CAMK1D | 0.80758078 |
| 84 | PLK1 | 0.80294128 |
| 85 | PRKAA1 | 0.79967822 |
| 86 | MAP2K7 | 0.79388960 |
| 87 | SGK3 | 0.79366024 |
| 88 | PRKCZ | 0.78021428 |
| 89 | CDC7 | 0.77739829 |
| 90 | PLK4 | 0.76001822 |
| 91 | STK24 | 0.75998540 |
| 92 | MKNK1 | 0.75591748 |
| 93 | PRKACG | 0.74462435 |
| 94 | TYK2 | 0.73240507 |
| 95 | SGK2 | 0.70881181 |
| 96 | CAMK2G | 0.70829434 |
| 97 | DYRK1B | 0.70824877 |
| 98 | JAK1 | 0.70570995 |
| 99 | PRKCE | 0.69159930 |
| 100 | MAP4K2 | 0.68766630 |
| 101 | MAP2K2 | 0.67267805 |
| 102 | TIE1 | 0.67206986 |
| 103 | CDK7 | 0.66606788 |
| 104 | CAMK2D | 0.66379963 |
| 105 | PDPK1 | 0.65182803 |
| 106 | PIK3CA | 0.64543564 |
| 107 | CDK9 | 0.63649337 |
| 108 | NTRK1 | 0.63043974 |
| 109 | PAK4 | 0.61368180 |
| 110 | EIF2AK2 | 0.61271323 |
| 111 | MYLK | 0.59827244 |
| 112 | YES1 | 0.59398698 |
| 113 | MAP2K1 | 0.58874850 |
| 114 | PRKD3 | 0.57933537 |
| 115 | PDGFRA | 0.56710226 |
| 116 | PRKACB | 0.56457473 |
| 117 | CSNK1D | 0.56356979 |
| 118 | MAP3K1 | 0.54462987 |
| 119 | EPHB2 | 0.53635289 |
| 120 | PBK | 0.53057983 |
| 121 | IRAK3 | 0.52334408 |
| 122 | PDK2 | 0.52315977 |
| 123 | RET | 0.52059239 |
| 124 | FGFR3 | 0.49874368 |
| 125 | PRKD1 | 0.48547244 |
| 126 | IGF1R | 0.48075276 |
| 127 | PRKCH | 0.47997646 |
| 128 | BRD4 | 0.47571134 |
| 129 | RPS6KA4 | 0.47309351 |
| 130 | PKN1 | 0.47125485 |
| 131 | CSNK1G1 | 0.46783446 |
| 132 | CSK | 0.46132094 |
| 133 | AKT2 | 0.45900428 |
| 134 | IRAK1 | 0.45316572 |
| 135 | AURKB | 0.45161554 |
| 136 | NLK | 0.45024009 |
| 137 | CDK6 | 0.44916076 |
| 138 | MAPK4 | 0.43989873 |
| 139 | CSNK1E | 0.43778433 |
| 140 | PRKCQ | 0.43763133 |
| 141 | CAMK1G | 0.42942543 |
| 142 | KDR | 0.42456791 |
| 143 | MINK1 | 0.42112389 |
| 144 | MAPK13 | 0.42069597 |
| 145 | LATS2 | 0.41919815 |
| 146 | MOS | 0.41707889 |
| 147 | ATM | 0.41487738 |
| 148 | OBSCN | 0.41329916 |
| 149 | MAP2K3 | 0.40578023 |
| 150 | CHEK2 | 0.39702269 |
| 151 | PAK6 | 0.38850670 |
| 152 | CAMK2B | 0.38265298 |
| 153 | CSNK1G2 | 0.37933321 |
| 154 | TBK1 | 0.37893378 |
| 155 | GRK1 | 0.36325526 |
| 156 | MAP3K14 | 0.34661736 |
| 157 | MAPK7 | 0.34317882 |
| 158 | AKT3 | 0.33919776 |
| 159 | PRKCA | 0.33811902 |
| 160 | ICK | 0.33404092 |
| 161 | MAP2K6 | 0.32825821 |
| 162 | FGFR1 | 0.32758149 |
| 163 | TGFBR2 | 0.31881841 |
| 164 | IRAK2 | 0.31282754 |
| 165 | PDK1 | 0.30852084 |
| 166 | CSNK1A1L | 0.30402031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.99056806 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.32254652 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.18560721 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.81343589 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.79407515 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71214151 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70488911 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.69101127 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.62250373 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54451227 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.46292715 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.28460899 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.26444713 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22812548 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.22045246 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.10893078 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09847609 |
| 18 | * Peroxisome_Homo sapiens_hsa04146 | 2.09689904 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95540921 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.93712293 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.92492483 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91994222 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80241239 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.79368524 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74887287 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.74779107 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73944500 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.72258288 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64348093 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.56358200 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.56091227 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53466810 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53277498 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52153069 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52025774 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.50732252 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48538199 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46916201 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38654828 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35813361 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.34580354 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34075677 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28002174 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25228090 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17501327 |
| 46 | * ABC transporters_Homo sapiens_hsa02010 | 1.14437352 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14011440 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08600998 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05915123 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00867402 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.00657995 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99397602 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98863673 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96639043 |
| 55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.84971057 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84778953 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.83452497 |
| 58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80175757 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78668844 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77667368 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76643284 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74660285 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74219271 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.71721066 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67423767 |
| 66 | Adherens junction_Homo sapiens_hsa04520 | 0.61429373 |
| 67 | Mismatch repair_Homo sapiens_hsa03430 | 0.60787918 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59804006 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54918787 |
| 70 | Cell cycle_Homo sapiens_hsa04110 | 0.53459556 |
| 71 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51469179 |
| 72 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.51200373 |
| 73 | Tight junction_Homo sapiens_hsa04530 | 0.50409476 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50179059 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48618374 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46076324 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45465705 |
| 78 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.44503248 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42997854 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42766330 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41999848 |
| 82 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.41533048 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41521370 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38249064 |
| 85 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37882144 |
| 86 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.36275118 |
| 87 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.35655066 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.33768894 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31275854 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.29729970 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29135224 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.28454725 |
| 93 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28181925 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27810581 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23088894 |
| 96 | Renin secretion_Homo sapiens_hsa04924 | 0.20116747 |
| 97 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.18662867 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18367133 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.12366225 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07468611 |
| 101 | Mineral absorption_Homo sapiens_hsa04978 | 0.06903577 |
| 102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.06274634 |
| 103 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.04249425 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1745333 |
| 105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1626798 |
| 106 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1387159 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1382988 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0838790 |
| 109 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0736111 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0706869 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0665931 |
| 112 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0579849 |
| 113 | Lysosome_Homo sapiens_hsa04142 | -0.0504898 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0388210 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0357233 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0356813 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0235131 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0150170 |
| 119 | Protein export_Homo sapiens_hsa03060 | -0.0072950 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0015687 |

